| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 2e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |